Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Gains U.S. Approval for Higher-Dose Copaxone Therapy
Teva Gains U.S. Approval for Higher-Dose Copaxone Therapy
Teva Gains U.S. Approval for Higher-Dose Copaxone Therapy
Submitted by
admin
on January 29, 2014 - 9:27am
Source:
Bloomberg
News Tags:
Teva
Copaxone
MS
multiple sclerosis
Headline:
Teva Gains U.S. Approval for Higher-Dose Copaxone Therapy
Do Not Allow Advertisers to Use My Personal information
